Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified

Healthsouth

(

HLS

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Healthsouth as such a stock due to the following factors:

  • HLS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $27.3 million.
  • HLS has traded 220,983 shares today.
  • HLS is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in HLS with the Ticky from Trade-Ideas. See the FREE profile for HLS NOW at Trade-Ideas

More details on HLS:

HealthSouth Corporation owns and operates inpatient rehabilitation hospitals in the United States. The company provides specialized rehabilitative treatment on an inpatient and outpatient basis. The stock currently has a dividend yield of 1.8%. HLS has a PE ratio of 20.9. Currently there are 7 analysts that rate Healthsouth a buy, 1 analyst rates it a sell, and 3 rate it a hold.

The average volume for Healthsouth has been 629,200 shares per day over the past 30 days. Healthsouth has a market cap of $4.1 billion and is part of the health care sector and health services industry. The stock has a beta of 1.35 and a short float of 6.6% with 10.24 days to cover. Shares are up 21.6% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Healthsouth as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

Highlights from the ratings report include:

  • Powered by its strong earnings growth of 232.25% and other important driving factors, this stock has surged by 33.30% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, HLS should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
  • HLS's revenue growth trails the industry average of 20.6%. Since the same quarter one year prior, revenues slightly increased by 6.7%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • HEALTHSOUTH CORP reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, HEALTHSOUTH CORP reported lower earnings of $2.23 versus $2.42 in the prior year. This year, the market expects an improvement in earnings ($2.28 versus $2.23).
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Providers & Services industry and the overall market, HEALTHSOUTH CORP's return on equity significantly exceeds that of both the industry average and the S&P 500.
  • The debt-to-equity ratio is very high at 3.76 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. Even though the debt-to-equity ratio is weak, HLS's quick ratio is somewhat strong at 1.21, demonstrating the ability to handle short-term liquidity needs.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null